These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 22767014

  • 1. The successful combined use of Impella LP 2.5 and intra-aortic balloon pump in ST-elevation myocardial infarction with refractory cardiogenic shock.
    Romeo F.
    J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):531-2. PubMed ID: 22767014
    [No Abstract] [Full Text] [Related]

  • 2. Mechanical versus pharmacologic support for cardiogenic shock.
    Dhar G, Jolly N.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):626-9. PubMed ID: 20049971
    [Abstract] [Full Text] [Related]

  • 3. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction.
    Wiktor DM, Sawlani N, Kanthi Y, Sipahi I, Fang JC, Blitz A.
    ASAIO J; 2010 Mar 01; 56(6):519-21. PubMed ID: 20938341
    [Abstract] [Full Text] [Related]

  • 4. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A.
    EuroIntervention; 2011 Aug 01; 7(4):437-41. PubMed ID: 21764661
    [Abstract] [Full Text] [Related]

  • 5. Commentary: successful combined use of the Impella Recover 2.5 device and intraaortic balloon pump support for cardiogenic shock after acute myocardial infarction.
    El Oakley R.
    ASAIO J; 2010 Aug 01; 56(6):517-8. PubMed ID: 21245797
    [No Abstract] [Full Text] [Related]

  • 6. Acute intraventricular thrombosis of an impella LP 5.0 device in an ST-elevated myocardial infarction complicated by cardiogenic shock.
    Ranc S, Sibellas F, Green L.
    J Invasive Cardiol; 2013 Jan 01; 25(1):E1-3. PubMed ID: 23293180
    [Abstract] [Full Text] [Related]

  • 7. [Cardiogenic shock complicating acute myocardial infarction: trends in management and outcome].
    Grazi M, Farina S, Assanelli E.
    Recenti Prog Med; 2010 Mar 01; 101(3):99-105. PubMed ID: 20461950
    [Abstract] [Full Text] [Related]

  • 8. Combined use of Impella device and intra-aortic balloon pump to improve survival in a patient in profound cardiogenic shock post cardiac arrest.
    Gupta A, Allaqaband S, Bajwa T.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):975-6. PubMed ID: 19521993
    [Abstract] [Full Text] [Related]

  • 9. Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature.
    Cubeddu RJ, Lago R, Horvath SA, Vignola PA, O'Neill W, Palacios IF.
    EuroIntervention; 2012 Apr 15; 7(12):1453-60. PubMed ID: 22522555
    [Abstract] [Full Text] [Related]

  • 10. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.
    Summaria F, Mustilli M, Sette A, Lanzillo C, Romagnoli E.
    Ther Adv Cardiovasc Dis; 2014 Feb 15; 8(1):28-31. PubMed ID: 24492986
    [Abstract] [Full Text] [Related]

  • 11. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G, Prando MD, Parodi F, Cordero G, Sansa M, Bongo AS, Campi A, Aralda D, Dellavesa P, Aina F, Lazzero M, Cernigliaro C.
    G Ital Cardiol; 1996 Dec 15; 26(12):1385-99. PubMed ID: 9162668
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined hemodynamic support with the Impella 2.5 device and intra-aortic balloon pump for management of refractory cardiogenic shock.
    Pavlidis AN, Redwood SR, Clapp BR.
    J Invasive Cardiol; 2014 May 15; 26(5):E50-1. PubMed ID: 24791724
    [Abstract] [Full Text] [Related]

  • 14. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction.
    Giesler GM, Gomez JS, Letsou G, Vooletich M, Smalling RW.
    Catheter Cardiovasc Interv; 2006 Aug 15; 68(2):263-6. PubMed ID: 16819772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction.
    Idelchik GM, Loyalka P, Kar B.
    Tex Heart Inst J; 2007 Aug 15; 34(2):204-8. PubMed ID: 17622370
    [Abstract] [Full Text] [Related]

  • 18. Impact of Timing of Impella Support in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Khalid N, Ahmad SA.
    Cardiovasc Revasc Med; 2022 Jun 15; 39():36-37. PubMed ID: 35379569
    [No Abstract] [Full Text] [Related]

  • 19. [Percutaneous insertion of a left ventricular assist device for cardiogenic shock in a patient with a myocardial infarction].
    Ottervanger JP, de Feijter P, Gardien M, Serruys PW.
    Ned Tijdschr Geneeskd; 2003 Jan 25; 147(4):164-6. PubMed ID: 12635549
    [Abstract] [Full Text] [Related]

  • 20. [Acute pump failure in myocardial infarction].
    Umezawa S, Hiroe M.
    Nihon Rinsho; 1992 Nov 25; 50 Suppl():326-32. PubMed ID: 1344364
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.